Neurocrine Biosciences, Inc. (BIT:1NBIX)
96.00
+1.30 (1.37%)
At close: May 2, 2025
Neurocrine Biosciences Revenue
In the year 2024, Neurocrine Biosciences had annual revenue of $2.36B USD with 24.81% growth. Neurocrine Biosciences had revenue of $627.70M in the quarter ending December 31, 2024, with 21.84% growth.
Revenue
$2.36B
Revenue Growth
+24.81%
P/S Ratio
4.21
Revenue / Employee
$1.31M
Employees
1,800
Market Cap
9.57B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.36B | 468.20M | 24.81% |
Dec 31, 2023 | 1.89B | 398.40M | 26.76% |
Dec 31, 2022 | 1.49B | 355.20M | 31.34% |
Dec 31, 2021 | 1.13B | 87.60M | 8.38% |
Dec 31, 2020 | 1.05B | 257.80M | 32.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Intesa Sanpaolo | 25.38B |
UniCredit | 23.99B |
Enel SpA | 75.71B |
Ferrari | 6.68B |
Assicurazioni Generali | 55.30B |
Eni S.p.A. | 90.96B |
Leonardo S.p.a. | 17.76B |
Stellantis | 156.88B |